Solu Therapeutics is a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas.
Market
Cancer, Immunology
Location
Boston,
MA,
US
Coinvestors
Eli Lilly and Company, Biovision Ventures, Pappas Capital, Hengdian Group Capital, The Leukemia & Lymphoma Society Therapy Acceleration Program, Longwood Fund, DCVC Bio, Sante Ventures, Astellas Venture Management, Alexandria Venture Investments